European countries diverged Wednesday on whether they would push ahead with giving their residents Johnson & Johnson’s COVID-19 vaccine after reports of very rare blood clots in a handful of recipients in the United States.
European countries diverged Wednesday on whether they would push ahead with giving their residents Johnson & Johnson’s COVID-19 vaccine after reports of very rare blood clots in a handful of recipients in the United States.